Medacta Group SA
SIX:MOVE
Relative Value
The Relative Value of one
MOVE
stock under the Base Case scenario is
hidden
CHF.
Compared to the current market price of 153.2 CHF,
Medacta Group SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
MOVE Competitors Multiples
Medacta Group SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
|
Medacta Group SA
SIX:MOVE
|
3.1B CHF | 5.1 | 35 | 19.4 | 32.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
194.9B USD | 4.4 | 29.9 | 16.9 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.4B USD | 17.7 | 62.4 | 47.6 | 57.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
138.7B USD | 5.5 | 42.7 | 21.7 | 26.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.4B USD | 3.8 | 27.4 | 15.3 | 22.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.1B USD | 5.7 | 39.5 | 23.5 | 32 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.3B EUR | 2 | 21.8 | 12 | 17 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.8B USD | 12 | 48.9 | 34.9 | 38.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.9B USD | 2.2 | 29.2 | 11.2 | 19 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.9B USD | 7.6 | 32.8 | 23.3 | 25.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
38.7B USD | 7.2 | 26.1 | 18.4 | 20.5 |